Nanobodies targeting ion channels: advancing therapeutics through precision and structural insights

Abstract

Ion channels, which are integral to cellular signaling and homeostasis, are implicated in a variety of diseases, including neurological disorders, cardiovascular conditions, and cancers. Despite their importance, targeting ion channels therapeutically is challenging due to issues such as structural conservation and dynamic conformational changes. Nanobodies, derived from camelid heavy-chain antibodies, have emerged as a transformative tool in biotherapeutics due to their small size, remarkable stability, and high specificity for epitope recognition. They represent a significant advancement in targeting ion channels, offering precision and adaptability not achievable with traditional antibodies or small molecules. This review provides an in-depth analysis of the structural and functional basis of ion channel modulation by nanobodies. We explore how they achieve their effects through diverse mechanisms, including direct pore blocking, allosteric modulation of gating, stabilization of specific conformational states, and isoform-selective recognition. We further examine their therapeutic applications, the potential for engineering multivalent constructs to enhance efficacy, and critical advancements in overcoming challenges like blood–brain barrier (BBB) penetration. Finally, we discuss recent clinical developments, the translational gap for ion channel targets, and the transformative potential of artificial intelligence in accelerating the design of next-generation nanobody-based therapeutics.